$Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series$

Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series

Non-platinum single agents are usually used for patients with platinum-resistant recurrent ovarian cancers (ROC). However, the efficacy of these drugs is limited. The aim of the present study was to evaluate the efficacy and adverse events (AE) of combination therapy with irinotecan and platinum (CP...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular and clinical oncology 2017-07, Vol.7 (1), p.51-55
Hauptverfasser:	Shibutani, Takashi, Takano, Masashi, Miyamoto, Morikazu, Yoshikawa, Tomoyuki, Aoyama, Tadashi, Soyama, Hiroaki, Hirata, Junko, Suzuki, Ayako, Sasa, Hidenori, Furuya, Kenichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia Anorexia Cancer therapies Chemotherapy Combination drug therapy Dosage and administration Drug dosages Drug therapy Irinotecan Medical imaging Medical prognosis Methods Mortality Neutropenia Oncology Ovarian cancer Patients Platinum Platinum compounds Response rates Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!